V-WAVE ANNOUNCES APPOINTMENT OF BILL HUGHES AS CHIEF FINANCIAL OFFICER

Seasoned Medical Device Executive Joins Breakthrough Structural Heart Company CAESAREA, ISRAEL AND AGOURA HILLS, CALIFORNIA – V-Wave Ltd., a cardiovascular device company developing proprietary, minimally invasive interatrial shunt devices for treating patients with...

V-WAVE RECEIVES CE MARK FOR THE VENTURA™ INTERATRIAL SHUNT SYSTEM

CE Mark for the Ventura™ Interatrial Shunt System is a significant milestone for V-Wave, as it recognizes that this therapeutic product conforms to the standards of the European Medical Device Directive V-Wave Ltd., a privately held medical device company developing...

WILLIAM T. ABRAHAM, MD, JOINS V-WAVE AS CHIEF MEDICAL OFFICER

Renowned heart failure cardiologist, Dr. William T. Abraham, makes this move to V-Wave after more than 16 years as Director of the Division of Cardiovascular Medicine at The Ohio State University. V-Wave Ltd., an early stage medtech company developing an implantable...

V-WAVE ANNOUNCES $28M SERIES B FINANCING

Funding to support further development of V-Wave’s Unidirectional Interatrial Shunt for the treatment of Heart Failure. V-Wave Ltd. announced that it has completed a Series B financing of $28M. New investors included Johnson & Johnson Innovation – JJDC Inc.,...